We are live on ! Find out more
TC

TwinBeech Capital Portfolio holdings

AUM $965M
1-Year Est. Return 0.23%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
-0.23%
3 Year Est. Return
-0.53%
5 Year Est. Return
-33.53%
10 Year Est. Return
AUM
$6.19B
AUM Growth
+$984M
Cap. Flow
+$679M
Cap. Flow %
10.98%
Top 10 Hldgs %
13.02%
Holding
961
New
353
Increased
134
Reduced
122
Closed
352

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$107M
2
SBUX icon
Starbucks
SBUX
+$99.9M
3
ROST icon
Ross Stores
ROST
+$94.2M
4
NKE icon
Nike
NKE
+$85.4M
5
HUM icon
Humana
HUM
+$74.4M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$79M
2
HD icon
Home Depot
HD
+$75.5M
3
FISV
Fiserv Inc
FISV
+$65.3M
4
HCA icon
HCA Healthcare
HCA
+$64.8M
5
MU icon
Micron Technology
MU
+$64.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.78%
2 Technology 19.13%
3 Healthcare 12.95%
4 Industrials 11.23%
5 Financials 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
601
Revolution Medicines
RVMD
$39.1B
$215K ﹤0.01%
7,486
-178,659
-96% -$4.29M
PB icon
602
Prosperity Bancshares
PB
$8.82B
$202K ﹤0.01%
+2,978
New +$174K
TVTX icon
603
Travere Therapeutics
TVTX
$5.2B
$185K ﹤0.01%
20,577
-208,209
-91% -$1.52M
LPSN icon
604
LivePerson
LPSN
$22.9M
$161K ﹤0.01%
2,839
+1,903
+203% +$87.6K
DRH icon
605
Diamondrock Hospitality Co
DRH
$2.67B
$160K ﹤0.01%
+17,014
New +$143K
ROIV icon
606
Roivant Sciences
ROIV
$24.3B
$157K ﹤0.01%
+13,952
New +$136K
PETS icon
607
PetMed Express
PETS
$43M
$107K ﹤0.01%
+14,122
New +$116K
AUPH icon
608
Aurinia Pharmaceuticals
AUPH
$1.92B
$91.8K ﹤0.01%
10,209
-135,136
-93% -$1.11M
CLOV icon
609
Clover Health Investments
CLOV
$2.28B
$25.5K ﹤0.01%
+26,798
New +$26.3K
A icon
610
Agilent Technologies
A
$39.7B
-243,232
Closed -$27.2M
AAL icon
611
American Airlines Group
AAL
$10.2B
-867,914
Closed -$11.1M
AAON icon
612
Aaon
AAON
$7.68B
-126,356
Closed -$7.19M
AAP icon
613
Advance Auto Parts
AAP
$3.54B
-32,673
Closed -$1.83M
ACA icon
614
Arcosa
ACA
$7.13B
-3,964
Closed -$285K
ACAD icon
615
Acadia Pharmaceuticals
ACAD
$4.45B
-316,555
Closed -$6.6M
ACHC icon
616
Acadia Healthcare
ACHC
$3.01B
-36,751
Closed -$2.58M
ACIW icon
617
ACI Worldwide
ACIW
$6.1B
-36,411
Closed -$821K
AEP icon
618
American Electric Power
AEP
$72.4B
-291,033
Closed -$21.9M
AFRM icon
619
Affirm
AFRM
$24.2B
-414,983
Closed -$8.83M
AHCO icon
620
AdaptHealth
AHCO
$1.53B
-274,321
Closed -$2.5M
AI icon
621
C3.ai
AI
$1.38B
-52,041
Closed -$1.33M
AKRO
622
DELISTED
Akero Therapeutics
AKRO
-54,780
Closed -$2.77M
ALC icon
623
Alcon
ALC
$33.7B
-57,254
Closed -$4.41M
ALGN icon
624
Align Technology
ALGN
$12.6B
-176,253
Closed -$53.8M
ALGT icon
625
Allegiant Air
ALGT
$2.73B
-11,995
Closed -$922K

Similar funds

TwinBeech Capital's Q4 2023 Portfolio in Review

As of Q4 2023, TwinBeech Capital held 961 positions worth $6.19B, up 19% from $5.21B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TwinBeech Capital deployed $679M of net new capital in Q4 2023, opening 353 new positions and adding to 134 existing holdings. Its largest new stake was Walmart Inc: 2,018,706 shares worth $106M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Fiserv Inc, an estimated $65.3M trimmed.

  • TwinBeech Capital's largest Q4 2023 buy was Walmart Inc: 2,018,706 shares worth $106M.
  • TwinBeech Capital added most to Ross Stores in Q4 2023, an estimated $94.2M increase.
  • TwinBeech Capital's biggest Q4 2023 reduction was Fiserv Inc, cutting an estimated $65.3M.
  • TwinBeech Capital fully exited Dollar General in Q4 2023, selling an estimated $79M.
  • TwinBeech Capital's ten largest holdings make up 13% of its $6.19B portfolio in Q4 2023.
  • TwinBeech Capital opened 353 new positions and closed 352 in Q4 2023.
  • TwinBeech Capital's portfolio value rose 19% quarter-over-quarter to $6.19B.

Based on TwinBeech Capital's 13F filing for Q4 2023, filed 14 Feb 2024.